These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
386 related articles for article (PubMed ID: 2498034)
21. Effects on sex hormone binding globulin of different oral contraceptives containing norethisterone and lynestrenol. Odlind V; Weiner E; Victor A; Johansson ED Br J Obstet Gynaecol; 1980 May; 87(5):416-21. PubMed ID: 6155933 [TBL] [Abstract][Full Text] [Related]
22. Comparison of contraceptive acceptability of levonorgestrel and ethinyl oestradiol administered in one three-phasic (Trionetta) and one monophasic (Neovletta) version. Carlborg L Contraception; 1983 May; 27(5):439-52. PubMed ID: 6349925 [TBL] [Abstract][Full Text] [Related]
23. Effect of low-dose oral contraceptives on androgenic markers and acne. Thorneycroft IH; Stanczyk FZ; Bradshaw KD; Ballagh SA; Nichols M; Weber ME Contraception; 1999 Nov; 60(5):255-62. PubMed ID: 10717776 [TBL] [Abstract][Full Text] [Related]
24. A prospective controlled study of the effect on blood pressure of contraceptive preparations containing different types and dosages of progestogen. Wilson ES; Cruickshank J; McMaster M; Weir RJ Br J Obstet Gynaecol; 1984 Dec; 91(12):1254-60. PubMed ID: 6440589 [TBL] [Abstract][Full Text] [Related]
25. Oral contraceptive tablets containing 20 and 30 micrograms of ethinyl estradiol with 150 micrograms desogestrel. Their influence on lipids, lipoproteins, sex hormone binding globulin and testosterone. Akerlund M; Almström E; Högstedt S; Nabrink M Acta Obstet Gynecol Scand; 1994 Feb; 73(2):136-43. PubMed ID: 8116352 [TBL] [Abstract][Full Text] [Related]
26. Selectivity and minimal androgenicity of norgestimate in monophasic and triphasic oral contraceptives. Anderson FD Acta Obstet Gynecol Scand Suppl; 1992; 156():15-21. PubMed ID: 1324552 [TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetics of gestagens: some problems. Fotherby K Am J Obstet Gynecol; 1990 Jul; 163(1 Pt 2):323-8. PubMed ID: 2115297 [TBL] [Abstract][Full Text] [Related]
28. Interrelationship of serum levonorgestrel and sex hormone-binding globulin levels following vaginal and oral administration of combined steroid contraceptive tablets. Abdalla KA; Shabaan MM; Stanczyk FZ Contraception; 1992 Feb; 45(2):111-8. PubMed ID: 1559334 [TBL] [Abstract][Full Text] [Related]
29. Oral contraceptives containing 20 or 30 micrograms ethinylestradiol and 150 micrograms desogestrel: pharmacokinetics and pharmacodynamic parameters. Jung-Hoffmann C; Fitzner M; Kuhl H Horm Res; 1991; 36(5-6):238-46. PubMed ID: 1823082 [TBL] [Abstract][Full Text] [Related]
30. Comparative studies of the ethynyl estrogens used in oral contraceptives. III. Effect on plasma gonadotropins. Goldzieher JW; de la Peña A; Chenault CB; Cervantes A Am J Obstet Gynecol; 1975 Jul; 122(5):625-36. PubMed ID: 1146928 [TBL] [Abstract][Full Text] [Related]
31. Serum levels of d-norgestrel, luteinizing hormone, follicle-stimulating hormone, estradiol, and progesterone in women during and following ingestion of combination oral contraceptives containing dl-norgestrel. Brenner PF; Mishell DR; Stanczyk FZ; Goebelsmann U Am J Obstet Gynecol; 1977 Sep; 129(2):133-40. PubMed ID: 900174 [TBL] [Abstract][Full Text] [Related]
32. [Influence of progestins on adverse effects of oral contraceptives]. Wynn V Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):425-30. PubMed ID: 12280210 [TBL] [Abstract][Full Text] [Related]
33. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids. Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162 [TBL] [Abstract][Full Text] [Related]
34. Comparison of the impact of vaginal and oral administration of combined hormonal contraceptives on hepatic proteins sensitive to estrogen. Sitruk-Ware RL; Menard J; Rad M; Burggraaf J; de Kam ML; Tokay BA; Sivin I; Kluft C Contraception; 2007 Jun; 75(6):430-7. PubMed ID: 17519148 [TBL] [Abstract][Full Text] [Related]
35. Changes in coagulation and anticoagulation in women taking low-dose triphasic oral contraceptives: a controlled comparative 12-month clinical trial. Notelovitz M; Kitchens CS; Khan FY Am J Obstet Gynecol; 1992 Nov; 167(5):1255-61. PubMed ID: 1442974 [TBL] [Abstract][Full Text] [Related]
36. Some estrogenic effects of two oral contraceptives consisting of norgestrel and two different doses of ethynylestradiol. Miller JF; Fotherby K; Bye PG; Elstein M Contraception; 1979 Jul; 20(1):5-10. PubMed ID: 573191 [TBL] [Abstract][Full Text] [Related]
37. Group comparison of serum ethinyl estradiol, SHBG and CBG levels in 83 women using two low-dose combination oral contraceptives for three months. Dibbelt L; Knuppen R; Jütting G; Heimann S; Klipping CO; Parikka-Olexik H Contraception; 1991 Jan; 43(1):1-21. PubMed ID: 1825969 [TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetics of ethinylestradiol and levonorgestrel after administration of two oral contraceptive preparations. Carol W; Klinger G; Jäger R; Kasch R; Brandstädt A Exp Clin Endocrinol; 1992; 99(1):12-7. PubMed ID: 1628691 [TBL] [Abstract][Full Text] [Related]
39. Clinical and hormonal effects of ethinylestradiol combined with gestodene and desogestrel in young women with acne vulgaris. Mango D; Ricci S; Manna P; Miggiano GA; Serra GB Contraception; 1996 Mar; 53(3):163-70. PubMed ID: 8689881 [TBL] [Abstract][Full Text] [Related]